Supply Chain

The Food and Drug Administration on Monday approved Teva Pharmaceuticals' new treatment for Huntington's disease, a fatal degenerative disorder.

Here are 11 drugs with potential safety risks, according to a new Food and Drug Administration report.

Three EpiPen consumers on Monday filed a lawsuit against Canonsburg, Pa.-based Mylan over the high prices for EpiPens, reports Reuters.

Sanofi Pasteur, the vaccines unit of Paris-based Sanofi, will pay $19.8 million as part of a settlement for improperly calculating drug prices and overcharging the U.S. Department of Veterans Affairs.

Boston Scientific Corp. will expand its portfolio of minimally invasive heart devices through the acquisition of Swiss devicemaker Symetis for $435 million.

 Northbrook, Ill.-based Astellas Pharma will purchase the Belgian drugmaker Ogeda for $853 million, reports Chicago Tribune.

St. Louis-based SSM Health offers a "pharmacy concierge" program to help patients get access to medications at lower costs, reports KSDK.

Before implementing new cost control measures to tackle high drug prices, President Donald Trump's administration and lawmakers should first work to update and improve existing drug price regulations, according to two drug policy leaders.

President Donald Trump's proposal to transform trade deals and impose high border taxes on Mexican imports could pose a large threat to the American medical device industry, reports Kaiser Health News.

Meridian Medical Technologies, which manufacturers EpiPens for Mylan, on Friday expanded its global recall of the life-saving devices to include the U.S. market, reports Reuters.